CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-29 | Kalb Michael Wayne SVP and CFO | Shares withheld for taxes | −1,040 | $7.50 | $8K | 130,310 |
| 2021-01-29 | Kalb Michael Wayne SVP and CFO | Option exercise · Restricted Stock Units | −26,000 | 0 | ||
| 2021-01-29 | Kalb Michael Wayne SVP and CFO | Option exercise · Restricted Stock Units | −12,733 | 12,733 | ||
| 2021-01-29 | Kalb Michael Wayne SVP and CFO | Option exercise · Restricted Stock Units | −1,528 | 10,693 | ||
| 2021-01-29 | Kalb Michael Wayne SVP and CFO | Option exercise · Restricted Stock Units | −1,528 | 10,693 | ||
| 2021-01-29 | Ketchum Steven B Chief Scientific Officer | Option exercise | +26,000 | 414,112 | ||
| 2021-01-29 | Ketchum Steven B Chief Scientific Officer | Option exercise | +12,733 | 426,845 | ||
| 2021-01-29 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −19,971 | $7.50 | $150K | 406,874 |
| 2021-01-29 | Ketchum Steven B Chief Scientific Officer | Option exercise | +1,528 | 408,402 | ||
| 2021-01-29 | Ketchum Steven B Chief Scientific Officer | Option exercise | +1,528 | 409,930 | ||
| 2021-01-29 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −1,564 | $7.50 | $12K | 408,366 |
| 2021-01-29 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −26,000 | 0 | ||
| 2021-01-29 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −12,733 | 12,733 | ||
| 2021-01-29 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −1,528 | 10,693 | ||
| 2021-01-29 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −1,528 | 10,693 | ||
| 2021-01-29 | Kennedy Joseph T General Counsel | Option exercise | +26,000 | 240,399 | ||
| 2021-01-29 | Kennedy Joseph T General Counsel | Option exercise | +12,733 | 253,132 | ||
| 2021-01-29 | Kennedy Joseph T General Counsel | Shares withheld for taxes | −15,351 | $7.50 | $115K | 237,781 |
| 2021-01-29 | Kennedy Joseph T General Counsel | Option exercise | +1,806 | 239,587 | ||
| 2021-01-29 | Kennedy Joseph T General Counsel | Option exercise | +1,806 | 241,393 |
Page 38 of 67 · 1,339 trades